Major trial aims to tailor breast cancer treatment, reduce harsh chemo
NCT ID NCT07239271
Summary
This large study is testing a new, personalized approach to treating HER2-positive breast cancer before surgery. It aims to see if treatment can be adjusted based on a patient's early response, potentially allowing some to receive less intense chemotherapy while others get stronger treatment if needed. The goal is to improve cure rates and reduce side effects for 2,000 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.